Letter: psoriasiform eruption during vedolizumab therapy-Reference-Cited by-同舟云学术

Letter: psoriasiform eruption during vedolizumab therapy

Published:2019-07-17 Issue:3 Volume:50 Page:342-343
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Garbo Giuseppe Maria¹^ORCID,Renna Sara¹^ORCID,Caputo Valentina²,Orlando Elisabetta³,Macaluso Fabio Salvatore¹^ORCID,Orlando Rosalba¹,Bongiorno Maria Rita²,Orlando Ambrogio¹

Affiliation:

1. IBD Unit, Villa Sofia Cervello Hospital; Palermo Italy

2. Department of Pro.M.I.S.E. "Giuseppe D'Alessandro," Section of Dermatology; University of Palermo, AOUP Paolo Giaccone; Palermo PA Italy

3. Department of Pro.M.I.S.E. "Giuseppe D'Alessandro," Section of Pathology; University of Palermo, AOUP Paolo Giaccone; Palermo PA Italy

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15389/fullpdf

Reference3 articles.

1. Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry;Chaparro;Aliment Pharmacol Ther,2018

2. Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease;Shivaji;Aliment Pharmacol Ther,2019

3. Letter: paradoxical skin eruptions during anti-TNF-α treatment of Crohn's disease;Murphy;Aliment Pharmacol Ther,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriasiform dermatitis in a girl with ulcerative colitis receiving vedolizumab;The Journal of Dermatology;2022-02-23

2. Vedolizumab;Reactions Weekly;2019-08